Soleno Therapeutics, Inc.SLNONASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P77
Within normal range
vs 2Y Ago
40.9x
Strong expansion
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 11.62% |
| Q3 2025 | 446.07% |
| Q2 2025 | 61.50% |
| Q1 2025 | -36.52% |
| Q4 2024 | -60.73% |
| Q3 2024 | 15.44% |
| Q2 2024 | -40.89% |
| Q1 2024 | -98.42% |
| Q4 2023 | 0.28% |
| Q3 2023 | -13.76% |
| Q2 2023 | 17.27% |
| Q1 2023 | -30.82% |
| Q4 2022 | -10.46% |
| Q3 2022 | -0.78% |
| Q2 2022 | 27.38% |
| Q1 2022 | 7.30% |
| Q4 2021 | -26.95% |
| Q3 2021 | 32.53% |
| Q2 2021 | -7.01% |
| Q1 2021 | -9.04% |
| Q4 2020 | -11.40% |
| Q3 2020 | 5.66% |
| Q2 2020 | -15.46% |
| Q1 2020 | -11.49% |
| Q4 2019 | -7.57% |
| Q3 2019 | -21.22% |
| Q2 2019 | -5.59% |
| Q1 2019 | 1.31% |
| Q4 2018 | -39.56% |
| Q3 2018 | 2.65% |
| Q2 2018 | -9.13% |
| Q1 2018 | 7.76% |
| Q4 2017 | -20.30% |
| Q3 2017 | 17.84% |
| Q2 2017 | -26.61% |
| Q1 2017 | 18.79% |
| Q4 2016 | 3.52% |
| Q3 2016 | 31.04% |
| Q2 2016 | -1.41% |
| Q1 2016 | -17.93% |